Latest AI and machine learning research in schizophrenia for healthcare professionals.
Brain imaging studies have revealed that functional and structural brain connectivity in the so-call...
INTRODUCTION: A faster and more accurate self-report screener for early psychosis is needed to promo...
Converging evidences from different lines of research suggest abnormalities in functional brain conn...
BACKGROUND: Predicting psychotic relapse is one of the major challenges in the daily care of schizop...
The relationship between neurocognition and functioning among patients with schizophrenia is well do...
UNLABELLED: The key to any computational drug repositioning is the availability of relevant data in ...
In the recent 5 years (2014-2018), there has been growing interest in the use of machine learning (M...
Primary psychogenic polydipsia (PPD) is a chronic, relapsing condition in which there is a disturban...
Stable phase schizophrenia is characterized by altered patterning in tryptophan catabolites (TRYCATs...
The requirement of innovative big data analytics has become a critical success factor for research i...
Machine learning is becoming an increasingly popular approach for investigating spatially distribute...
Cognitive behavioural therapy for psychosis (CBTp) involves helping patients to understand and refra...
OBJECTIVE: Structural MRI (sMRI) increasingly offers insight into abnormalities inherent to schizoph...
Structural brain abnormalities in schizophrenia have been well characterized with the application of...
BACKGROUND: Technological advances are enabling us to collect multimodal datasets at an increasing d...
Machine learning is a method for predicting clinically relevant variables, such as opportunities for...
Combinations of new antidepressants like duloxetine and second-generation antipsychotics like quetia...
The human cerebellum plays an essential role in motor control, is involved in cognitive function (i....
This work presents a novel approach to finding linkage/association between multimodal brain imaging ...
Dubiety exists over whether clinical symptoms of schizophrenia can be distinguished from affective p...
Development of new medications is a lengthy and costly process, and drug repositioning might help to...